Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One Versus Two Doses of Tranexamic Acid in Hip Fracture Surgery
NCT07432737Recruiting
- Sponsor
- University Hospital for Surgical Diseases St. Naum Ohridski
- Start
- Feb 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in hip fracture (2 arms), sponsored by University Hospital for Surgical Diseases St. Naum Ohridski. Primary endpoint: Incidence of allogeneic blood transfusion. Started Feb 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT07432737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07432737.